Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans
- 12 November 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 344 (8933), 1323-1328
- https://doi.org/10.1016/s0140-6736(94)90693-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Risk for Developing Tuberculosis among Anergic Patients Infected with HIVAnnals of Internal Medicine, 1993
- Tuberculosis and HIV Infection in Sub-Saharan AfricaPublished by American Medical Association (AMA) ,1992
- An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1992
- Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- The Influence of Human Immunodeficiency Virus Infection on Tuberculosis in Kampala. UgandaAmerican Review of Respiratory Disease, 1991
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Overview and Epidemiologic Assessment of the Current Global Tuberculosis Situation with an Emphasis on Control in Developing CountriesClinical Infectious Diseases, 1989
- Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in east Africa third report of fifth investigationTubercle, 1973
- A second international co-operative investigation into thiacetazone side-effects Rashes on two thiacetazone containing regimensTubercle, 1971
- An international co-operative investigation into thiacetazone (thioacetazone) side-effectsTubercle, 1966